144 related articles for article (PubMed ID: 23898852)
1. Mood disorders medications: predictors of nonadherence - review of the current literature.
Pompili M; Venturini P; Palermo M; Stefani H; Seretti ME; Lamis DA; Serafini G; Amore M; Girardi P
Expert Rev Neurother; 2013 Jul; 13(7):809-25. PubMed ID: 23898852
[TBL] [Abstract][Full Text] [Related]
2. Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk.
Pompili M; Serafini G; Del Casale A; Rigucci S; Innamorati M; Girardi P; Tatarelli R; Lester D
Expert Rev Neurother; 2009 Jul; 9(7):985-1004. PubMed ID: 19589049
[TBL] [Abstract][Full Text] [Related]
3. Medication Adherence Among Children and Adolescents with Severe Mental Illness: A Systematic Review and Meta-Analysis.
Edgcomb JB; Zima B
J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):508-520. PubMed ID: 30040434
[TBL] [Abstract][Full Text] [Related]
4. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
[TBL] [Abstract][Full Text] [Related]
5. Role of adverse effects in medication nonadherence in bipolar disorder.
Mago R; Borra D; Mahajan R
Harv Rev Psychiatry; 2014; 22(6):363-6. PubMed ID: 25377611
[TBL] [Abstract][Full Text] [Related]
6. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.
Johnson FR; Ozdemir S; Manjunath R; Hauber AB; Burch SP; Thompson TR
Med Care; 2007 Jun; 45(6):545-52. PubMed ID: 17515782
[TBL] [Abstract][Full Text] [Related]
7. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
Bolton JM; Robinson J; Sareen J
J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
[TBL] [Abstract][Full Text] [Related]
8. [Alpha-interferon and mental disorders].
Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
[TBL] [Abstract][Full Text] [Related]
9. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
10. Classifying mood disorders by age-at-onset instead of polarity.
Benazzi F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784
[TBL] [Abstract][Full Text] [Related]
11. Review of medication adherence in children and adults with ADHD.
Adler LD; Nierenberg AA
Postgrad Med; 2010 Jan; 122(1):184-91. PubMed ID: 20107302
[TBL] [Abstract][Full Text] [Related]
12. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders.
Schaffer A; McIntosh D; Goldstein BI; Rector NA; McIntyre RS; Beaulieu S; Swinson R; Yatham LN;
Ann Clin Psychiatry; 2012 Feb; 24(1):6-22. PubMed ID: 22303519
[TBL] [Abstract][Full Text] [Related]
13. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
14. Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus.
Daleboudt GM; Broadbent E; McQueen F; Kaptein AA
Arthritis Care Res (Hoboken); 2011 Mar; 63(3):342-50. PubMed ID: 21120967
[TBL] [Abstract][Full Text] [Related]
15. Medication adherence: a review of the literature and implications for clinical practice.
Julius RJ; Novitsky MA; Dubin WR
J Psychiatr Pract; 2009 Jan; 15(1):34-44. PubMed ID: 19182563
[TBL] [Abstract][Full Text] [Related]
16. Adherence to treatment in mood disorders.
Byrne N; Regan C; Livingston G
Curr Opin Psychiatry; 2006 Jan; 19(1):44-9. PubMed ID: 16612178
[TBL] [Abstract][Full Text] [Related]
17. Strategies for increasing treatment adherence in bipolar disorder.
Thase ME
J Clin Psychiatry; 2012 Feb; 73(2):e08. PubMed ID: 22401485
[TBL] [Abstract][Full Text] [Related]
18. Mood and personality-based models of substance use.
Chakroun N; Johnson EI; Swendsen J
Psychol Addict Behav; 2010 Mar; 24(1):129-36. PubMed ID: 20307120
[TBL] [Abstract][Full Text] [Related]
19. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States.
Sun SX; Liu GG; Christensen DB; Fu AZ
Curr Med Res Opin; 2007 Oct; 23(10):2305-12. PubMed ID: 17697454
[TBL] [Abstract][Full Text] [Related]
20. Association of anxious and depressive symptoms with medication nonadherence in patients with stable coronary artery disease.
Dempe C; Jünger J; Hoppe S; Katzenberger ML; Möltner A; Ladwig KH; Herzog W; Schultz JH
J Psychosom Res; 2013 Feb; 74(2):122-7. PubMed ID: 23332526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
